Global Demineralized Bone Matrix and Demineralized Allograft Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Demineralized Bone Matrix and Demineralized Allograft market size was valued at USD 576.2 million in 2022 and is forecast to a readjusted size of USD 890.3 million by 2029 with a CAGR of 6.4% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Demineralized bone matrix (DBM) is allograft bone that has had the inorganic mineral removed, leaving behind the organic "collagen" matrix. It was first discovered by Marshall Urist in 1965 that the removal of the bone mineral exposes more biologically active bone morphogenetic proteins. These growth factors modulate the differentiation of progenitor cells into osteoprogenitor cells, which are responsible for bone and cartilage formation. As a result of the demineralization process, DBM is more biologically active than undemineralized bone grafts; conversely the mechanical properties are significantly diminished.
This report is a detailed and comprehensive analysis for global Demineralized Bone Matrix and Demineralized Allograft market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Demineralized Bone Matrix and Demineralized Allograft market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Demineralized Bone Matrix and Demineralized Allograft market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Demineralized Bone Matrix and Demineralized Allograft market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Demineralized Bone Matrix and Demineralized Allograft market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Demineralized Bone Matrix and Demineralized Allograft
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Demineralized Bone Matrix and Demineralized Allograft market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, J &J (DePuy Synthes), SeaSpine, Xtant Medical and Zimmer Biomet, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Demineralized Bone Matrix and Demineralized Allograft market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Gel
Putty
Putty with Chips
Others
Market segment by Application
Dental Surgery
Spine Surgery
Trauma Surgery
Major players covered
Medtronic
J &J (DePuy Synthes)
SeaSpine
Xtant Medical
Zimmer Biomet
Stryker
Straumann
Wright Medical Group
Hans Biomed
Arthrex
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Demineralized Bone Matrix and Demineralized Allograft product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Demineralized Bone Matrix and Demineralized Allograft, with price, sales, revenue and global market share of Demineralized Bone Matrix and Demineralized Allograft from 2018 to 2023.
Chapter 3, the Demineralized Bone Matrix and Demineralized Allograft competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Demineralized Bone Matrix and Demineralized Allograft breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Demineralized Bone Matrix and Demineralized Allograft market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Demineralized Bone Matrix and Demineralized Allograft.
Chapter 14 and 15, to describe Demineralized Bone Matrix and Demineralized Allograft sales channel, distributors, customers, research findings and conclusion.